Integration of retifanlimab into the standard of care first-line therapy of advanced squamous anal cancer-lessons learned and open questions.
Saved in:
| Title: | Integration of retifanlimab into the standard of care first-line therapy of advanced squamous anal cancer-lessons learned and open questions. |
|---|---|
| Authors: | Modest DP; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Hofheinz RD; Mannheim Cancer Center, Universitätsmedizin Mannheim, University of Heidelberg, Mannheim, Germany. Electronic address: ralf.hofheinz@umm.de. |
| Source: | Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2026 May 29. Date of Electronic Publication: 2026 May 29. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1569-8041 |
|---|---|
| DOI: | 10.1016/j.annonc.2026.05.706 |
